Who are the key players/companies in the global peripheral artery disease market?

Some of the major players in the global peripheral artery disease market include Abbott Laboratories, AngioDynamics, B. Braun Melsungen AG, Becton Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC, Koninklijke Philips N.V., Medtronic plc, and Terumo Corporation.

Peripheral Artery Disease Market Size, Report

Peripheral Artery Disease Market Report by Type (Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories), End User (Hospitals, Specialty Clinics, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A5822

Buy Now New Year Sale

Market Overview:

The global peripheral artery disease market size reached USD 4.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.7 Billion by 2033, exhibiting a growth rate (CAGR) of 4.98% during 2025-2033. The rising number of geriatric populations, various technological innovations in the diagnosis and treatment, increasing adoption of home care settings, improvement in healthcare infrastructure, and changing living standards of individuals are propelling the market growth.

Report Attribute	Key Statistics
Base Year	2024
Forecast Years	2025-2033
Historical Years	2019-2024
Market Size in 2024	USD 4.9 Billion
Market Forecast in 2033	USD 7.7 Billion
Market Growth Rate (2025-2033)	4.98%

Peripheral artery disease (PAD) is a cardiovascular disorder wherein constricted arteries restrict blood flow to the limbs. It results in hair loss, leg numbness, feet or toe sores, painful cramps in hips and thighs, coldness and weak pulse in legs, and erectile dysfunction among men. It is caused when a plaque, also known as atherosclerosis, develops in leg arteries that carry oxygen and nutrient-rich blood from the heart to the arms and legs. It is diagnosed using the ankle-brachial index, ultrasound scan, angiography, blood tests, doppler and ultrasound (duplex) imaging, computed tomographic angiography (CT), and magnetic resonance angiography (MRA).

Peripheral Artery Disease Market

Peripheral Artery Disease Market Trends:

Changing Living Standards of Individuals

People are increasingly suffering from peripheral artery disease (PAD) due to lifestyle-related factors, such as diabetes, obesity, hypertension, and smoking. As global rates of these conditions increase, particularly in regions with aging populations, more individuals are at risk of PAD. Diabetes contributes to atherosclerosis, which narrows arteries and restricts blood flow, leading to PAD. As a result, the demand for diagnostic tools and treatments, such as angioplasty, stenting, and bypass surgery, is rising. Additionally, the global burden of cardiovascular diseases (CVDs) is pushing healthcare systems to focus on early detection and management of PAD.

Aging Population

The global aging population across the globe is contributing to peripheral artery disease market growth. Older adults face a higher risk of developing PAD owing to age-related vascular changes and atherosclerosis. As people age, their arteries naturally lose elasticity, which can result in narrowed or blocked arteries, a hallmark of PAD. This demographic shift drives demand for healthcare services including diagnostics, preventive treatments, and minimally invasive (MI) interventions like angioplasty and stent placement. In line with this, healthcare providers are increasingly focusing on addressing the needs of elderly patients, who often have complex health profiles, which is thereby increasing the peripheral artery disease market share.

Technological Advancements

Technological innovations in the diagnosis and treatment of peripheral artery disease (PAD) are significantly driving market growth. MI techniques such as endovascular therapies are revolutionizing PAD treatment by reducing recovery times and improving patient outcomes. Devices like drug-coated balloons, atherectomy systems, and advanced stents benefit in improving patient outcome without the need for open surgery. These technologies not only improve the efficacy of treatment but also make it accessible to a broader range of patients, including those who might not tolerate invasive procedures, thereby increasing peripheral artery disease market share. Additionally, improvements in diagnostic imaging are allowing for more accurate and earlier detection of PAD, which is critical in preventing complications such as limb amputation.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global peripheral artery disease market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on type and end user.

Breakup by Type:

Peripheral Angioplasty Balloons
Peripheral Stents
Peripheral Catheters
Inferior Vena Cava (IVC) Filters
Plaque Modification Devices
Hemodynamic Flow Alteration Devices
Peripheral Accessories

Breakup by End User:

Hospitals
Specialty Clinics
Others

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

Competitive Landscape:

The peripheral artery disease market research report has also provided a comprehensive analysis of the competitive landscape in the global market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:

Abbott Laboratories
AngioDynamics
B. Braun Melsungen AG
Becton Dickinson and Company
Biotronik SE & Co. KG
Boston Scientific Corporation
Cardinal Health Inc.
Cook Medical LLC
Koninklijke Philips N.V.
Medtronic plc
Terumo Corporation

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Peripheral Artery Disease Market Recent Developments:

8 February 2023: Abbott and Cardiovascular Systems, Inc. (CSI) announced a definitive agreement for Abbott to acquire CSI, a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease. The acquisition of CSI will add new, complementary technologies to Abbott's leading vascular device offerings.

Report Coverage:

Report Features	Details
Base Year of the Analysis	2024
Historical Period	2019-2024
Forecast Period	2025-2033
Units	Billion USD
Segment Coverage	Type, End User, Region
Region Covered	Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered	United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered	Abbott Laboratories, AngioDynamics, B. Braun Melsungen AG, Becton Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC, Koninklijke Philips N.V., Medtronic plc and Terumo Corporation.
Customization Scope	10% Free Customization
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report

The global peripheral artery disease market was valued at USD 4.9 Billion in 2024.

We expect the global peripheral artery disease market to exhibit a CAGR of 4.98% during 2025-2033.

The rising prevalence of cardiac diseases, along with the growing adoption of Minimally Invasive Surgeries (MIS), as they offer less postoperative pain, shortened hospital stay, faster recovery times, etc., is primarily driving the global peripheral artery disease market.

The sudden outbreak of the COVID-19 pandemic had led to the postponement of elective peripheral artery disease surgical procedures to reduce the risk of the coronavirus infection upon hospital visits and interaction with medical equipment or healthcare professionals.

Based on the type, the global peripheral artery disease market can be segmented into peripheral angioplasty balloons, peripheral stents, peripheral catheters, Inferior Vena Cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, and peripheral accessories. Currently, peripheral stents hold the majority of the global market share.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global peripheral artery disease market include Abbott Laboratories, AngioDynamics, B. Braun Melsungen AG, Becton Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC, Koninklijke Philips N.V., Medtronic plc, and Terumo Corporation.

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Purchase Options New Year Sale

Inquire Before Buying

Speak to an Analyst

Request Brochure

Request Customization

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.